10-Q: Kopin Q3 2025: Litigation Relief Boosts Net Income

Kopin Corporation reported a significant net income for Q3 2025, driven by a reduction in litigation accruals, despite a decrease in total revenues.

Summary

• Net income for the three months ended September 27, 2025, was $4.08 million, a substantial improvement from a net loss of $3.46 million in the prior year period.
• Net loss for the nine months ended September 27, 2025, was $4.20 million, significantly better than the $41.93 million net loss in the prior year period.
• Total revenues decreased by 10.2% to $11.96 million for the three months ended September 27, 2025, compared to $13.32 million in the prior year.
• Total revenues decreased by 13.2% to $30.96 million for the nine months ended September 27, 2025, compared to $35.69 million in the prior year.
• Accrued litigation damages were reduced by $5.1 million in Q3 2025, from $24.8 million to $19.7 million, following a post-trial order in the BlueRadios case.
• Cash and cash equivalents, including restricted cash, increased to $27.56 million at September 27, 2025, from $15.21 million at the beginning of the period.
• Working capital decreased to $16.9 million at September 27, 2025, from $18.9 million at December 28, 2024.
• Subsequent to the quarter, Kopin completed a PIPE financing raising $38.1 million net proceeds and a strategic investment from Theon International Plc for $15 million, including an $8.0 million acquisition of a 49% interest in Kopin Europe Ltd. and $7.0 million for Series A Convertible Preferred Stock.
• Management concluded that the company will be able to continue as a going concern for at least the next twelve months due to recent financing activities.
• Material weaknesses in internal control over financial reporting persist, as disclosed in the Annual Report on Form 10-K for the fiscal year ended December 28, 2024.

Sentiment

Score: 6

Explanation: While the company reported a net income for the quarter, this was primarily due to a one-time reduction in litigation accruals rather than improved operational profitability. Revenues declined, and operating losses persist for the nine-month period. However, the successful capital raises and strategic investment, along with the resolution of the 'going concern' doubt, provide a much-needed liquidity boost and strategic direction, offsetting some of the operational weaknesses. The ongoing material weaknesses in internal controls remain a concern.

Positives

• Reported a net income of $4.08 million for the three months ended September 27, 2025, a significant turnaround from a $3.46 million net loss in the comparable prior year period.
• Reduced the net loss for the nine months ended September 27, 2025, to $4.20 million, a substantial improvement from a $41.93 million net loss in the prior year period.
• Accrued litigation damages were reduced by $5.1 million in Q3 2025, from $24.8 million to $19.7 million, following a favorable post-trial order in the BlueRadios case that denied a permanent injunction and prejudgment interest.
• Successfully completed a Private Investment in Public Equity (PIPE) financing on September 30, 2025, generating $38.1 million in net proceeds.
• Secured a $15 million strategic investment from Theon International Plc on October 16, 2025, which included an $8.0 million sale of a 49% interest in Kopin Europe Ltd. and $7.0 million from the sale of Series A Convertible Preferred Stock.
• Management has concluded that the company will be able to continue as a going concern for at least the next twelve months, addressing previous substantial doubt.
• Cash and cash equivalents, including restricted cash, increased to $27.56 million at September 27, 2025, from $15.21 million at the beginning of the period.
• Awarded a $15.4 million Other Transaction Agreement (OTA) for the development of ultra-bright, full-color MicroLED displays for ground soldier augmented reality (AR) applications, expected to increase funded R&D revenues in fiscal year 2026.
• Industrial applications revenue increased for both the three months ($0.75 million vs $0.49 million) and nine months ($2.17 million vs $1.88 million) ended September 27, 2025, primarily due to growth in public safety applications.

Negatives

• Total revenues decreased by 10.2% for the three months ended September 27, 2025, to $11.96 million from $13.32 million in the prior year.
• Total revenues decreased by 13.2% for the nine months ended September 27, 2025, to $30.96 million from $35.69 million in the prior year.
• Net product revenues decreased for both the three-month ($10.69 million vs $10.92 million) and nine-month ($27.42 million vs $31.00 million) periods.
• Research and development revenues decreased for both the three-month ($1.20 million vs $2.27 million) and nine-month ($3.34 million vs $4.34 million) periods, primarily due to decreased funding for U.S. defense programs.
• Cost of product revenues as a percentage of net product revenues increased to 79% for the three months and 84% for the nine months ended September 27, 2025, compared to 76% and 82% in the prior year periods, due to lower volumes and higher fixed costs per unit for training and simulation and 3DAOI products.
• Working capital decreased to $16.9 million at September 27, 2025, from $18.9 million at December 28, 2024.
• Equity investments experienced impairment losses of $0.4 million in Q3 2025 and $0.5 million for the nine months ended September 27, 2025.
• Lightning Silicon Technology, Inc. (LST), a related party in which Kopin held a 20% equity stake, ceased operations in Q3 2025.
• Material weaknesses in internal control over financial reporting persist, as identified in the Annual Report on Form 10-K for the fiscal year ended December 28, 2024.

Risks

• Ability to source semiconductor components and other raw materials amidst continued intermittent shortages, including from new and alternative suppliers.
• Ability to prosecute and defend proprietary technology aggressively or successfully.
• Ability to recruit and retain personnel with experience and expertise relevant to the business.
• Ability to invest in research and development to achieve profitability even during periods when not profitable.
• Disruptions or delays in supply chains, particularly for semiconductor components, whether resulting from regional or global geopolitical developments, changes imposed by the new U.S. presidential administration, the current U.S. government shutdown, or otherwise.
• Costs and outcomes relating to any disputes, governmental inquiries or investigations, regulatory proceedings, legal proceedings or litigation, including the ongoing appeal of the BlueRadios judgment.
• Ability to continue to introduce new products in target markets.
• Ability to generate revenue growth and positive cash flow, and reach profitability.
• Strengthening of the U.S. dollar and its effects on the price of products in foreign markets.
• Impact of new regulations and customer demands relating to conflict minerals.
• Ability to obtain a competitive advantage in the wearable technologies market through its extensive portfolio of patents, trade secrets and non-patented know-how.
• Ability to grow within targeted markets.
• The importance of small form factor displays in the development of defense, consumer, and industrial products such as thermal weapon sights, safety equipment, virtual and augmented reality gaming, training and simulation products and metrology tools.
• Suitability of properties for needs for the foreseeable future.
• Need to achieve and maintain positive cash flow and profitability.
• Dependence on a Taiwanese foundry for AMLCD display products and Chinese, Korean, and European foundries for OLED display products; a disruption could lead to significant delays in identifying and qualifying new sources.
• Inability to increase prices due to the implementation or increase in tariffs, duties, and other taxes could negatively impact gross margin and overall profitability.
• Uncertainty regarding the acceptance of new products, such as the new product for the 3D automated optical inspection (3DAOI) market.
• Risk that required milestones in R&D contracts may be delayed or not met, which can affect the timing of revenue recognition.
• Material weaknesses in internal control over financial reporting persist, potentially affecting the timely, complete, and accurate recording and disclosures across multiple financial statement areas.

Future Outlook

Management believes funded research and development revenues will increase in fiscal year 2026 compared to fiscal year 2025, contingent on meeting required milestones in new contracts, such as the $15.4 million OTA for MicroLED displays. The company expects to expand Kopin Europe Ltd. operations through new product development, though the timing of revenue generation from these products is uncertain. Kopin anticipates incurring significant operating losses and negative cash flow from operations in the foreseeable future and expects capital expenditures of $1.0 million to $2.0 million in 2025. The appeal of the BlueRadios litigation is expected to conclude by mid-2027.

Management Comments

• "Management has concluded that the Company will be able to continue as a going concern for at least the next twelve months from the issuance of these financial statements."
• "We believe funded research and development revenues will increase in fiscal year 2026 as compared to fiscal year 2025."
• "Our ability to compete in this market [3DAOI] will rely upon acceptance of this new product which we are unable to forecast."
• "We expect to expand the operations of KEL through the development of new products. We are unable to forecast when the products would be available, if successfully developed, to generate revenue."
• "We expect to continue to incur significant operating losses and negative cash flow from operations in the foreseeable future."

Industry Context

Kopin operates in the specialized microdisplay and optical solutions market, serving defense, enterprise, medical, and consumer sectors. The defense sector remains a significant revenue driver, with new contracts like the $15.4 million OTA for MicroLED displays for ground soldier AR applications indicating continued investment in advanced display technologies for military use, despite a decrease in overall R&D funding. The industrial market shows growth, particularly in public safety applications, while the 3D automated optical inspection (3DAOI) market faces challenges with new product acceptance. The company faces global supply chain issues, particularly for semiconductor components, a common challenge across many tech industries. Strategic partnerships, such as the one with Theon International Plc, are crucial for expanding international operations and co-developing military products, reflecting a trend towards collaboration in high-tech defense sectors.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to global benchmarks for direct comparison.
• The increase in cost of product revenues as a percentage of net product revenues due to lower volumes and higher fixed costs per unit for training and simulation and 3DAOI products suggests potential challenges in achieving economies of scale or managing production efficiency compared to industry leaders.
• The persistence of material weaknesses in internal control over financial reporting, despite remediation efforts, indicates a lag behind best practices in corporate governance and financial reporting for publicly traded companies.

Management Changes

Corporate Governance

Legal Proceedings

• **BlueRadios, Inc. v. Kopin Corporation, Inc. (Civil Action No. 16-02052-JLK, D. Col.):** On September 5, 2025, a post-trial order was entered, awarding BlueRadios $19.7 million in damages, but denying a permanent injunction and prejudgment interest. Kopin had previously accrued $24.8 million for this matter, resulting in a $5.1 million benefit recognized in Q3 2025. On October 2, 2025, Kopin posted a $23.0 million supersedeas bond (covering the judgment, legal expenses, and interest) by depositing $24.2 million with its bank, which issued a Letter of Credit to a surety company. This $23.0 million is classified as Restricted Cash. On October 7, 2025, Kopin filed an appeal of the $19.7 million judgment. BlueRadios has cross-appealed the denial of a permanent injunction and earlier partial summary judgment orders. The appeal is expected to conclude by mid-2027. Accrued litigation liability as of September 27, 2025, is $19.7 million, with approximately $0.1 million in related interest. On September 26, 2025, a Mutual Release agreement with Kopin's lawyers reduced unpaid accrued legal expenses by $3.3 million to $1.9 million.

Related Party Transactions

• **Solos Technology Limited (Solos Technology) / Solos Incorporation (Solos Inc.):** Kopin sold and licensed assets of its SolosTM product line and WhisperTM Audio technology to Solos Technology in 2019, receiving a 20.0% equity stake in Solos Inc. As of September 27, 2025, Kopin had $0 receivables outstanding from Solos Technology (down from $30,000 at December 28, 2024). Kopin's former Chairman and founder of Solos Inc., Dr. John C.C. Fan, has an investment in Solos Inc. The equity investment in Solos Inc. had a carrying value of $0.2 million at September 27, 2025, and December 28, 2024. Sales to Solos Technology were $0 for Q3 2025 and YTD Q3 2025 (compared to $33,288 for Q3 2024 and YTD Q3 2024).
• **HMDmd. Inc.:** Kopin has warrants to purchase shares of Preferred Stock of HMDmd. The fair value of the investment was $0.3 million at September 27, 2025, and December 28, 2024. Sales to HMDmd, Inc. were $1,370 for Q3 2025 ($76,918 for Q3 2024) and $700,955 for YTD Q3 2025 ($299,177 for YTD Q3 2024). Payables to HMDmd, Inc. were $0 at September 27, 2025 (compared to $279,150 at December 28, 2024).
• **Lightning Silicon Technology, Inc (LST):** Kopin entered into LST Agreements in January 2023, issuing a license for OLED technology and receiving a 20.0% equity stake in LST. LST ceased operations in Q3 2025. Kopin's former Chairman and founder of LST, Dr. John C.C. Fan, has an individual ownership interest in LST. Purchases from LST were $65,000 for Q3 2025 ($924 for Q3 2024) and $116,800 for YTD Q3 2025 ($6,650 for YTD Q3 2024). Payables to LST were $0 at September 27, 2025 (compared to $1,228 at December 28, 2024).
• **RealWear Inc. (RealWear):** Kopin has an equity investment in RealWear with a carrying value of $0.4 million at September 27, 2025 (after impairment charges). Sales to RealWear, Inc. were $68,754 for Q3 2025 ($94,854 for Q3 2024) and $189,216 for YTD Q3 2025 ($311,994 for YTD Q3 2024). Receivables from RealWear, Inc. were $68,754 at September 27, 2025 ($94,884 at December 28, 2024).
• **Dr. John C.C. Fan (former President, CEO, and Chairman):** Received $750,000 of severance payments for fiscal years 2024 and 2023. Continues to receive $40,000 for medical benefits annually since 2023, and will continue through 2032.
• **Vuzix Corp:** Purchases from Vuzix Corp were $0 for YTD Q3 2025 (compared to $11,905 for YTD Q3 2024).

Stakeholder Impact

• **Shareholders:** Experience dilution from recent equity offerings (PIPE, pre-funded warrants, ATM sales) and potential future conversion of Series A Preferred Stock. Benefit from improved liquidity and resolution of 'going concern' doubt, reducing immediate financial risk. The appeal of the BlueRadios judgment introduces continued uncertainty, but the bond mitigates immediate cash outflow. Strategic investment from Theon and new R&D contracts offer potential for future growth and value creation. Persistent material weaknesses in internal controls could impact investor confidence and financial reporting reliability.
• **Employees:** Continue to receive stock-based compensation. New CFO, Erich Manz, received a significant inducement award. The cessation of LST operations could impact employees involved with that technology.
• **Customers:** Benefit from continued product development in defense, industrial, and medical applications. Face potential risks from supply chain issues for semiconductor components, which could impact product availability and delivery times. Acceptance of new products for the 3DAOI market is uncertain.
• **Suppliers:** Face concentration risk due to reliance on specific foundries (Taiwanese for AMLCD, Chinese, Korean, European for OLED). Intermittent shortages of semiconductor components could strain relationships and increase costs.
• **Creditors:** Benefit from improved liquidity from recent capital raises, which reduces immediate credit risk. The $23.0 million supersedeas bond for the BlueRadios judgment is secured by a deposit with the bank, impacting available cash but providing security for the judgment.

Next Steps

• Continue implementation of a remediation plan to improve internal control over financial reporting.
• Appeal the $19.7 million judgment in the BlueRadios litigation, with the appeal expected to conclude by mid-2027.
• Expand operations of Kopin Europe Ltd. through the development of new products in partnership with Theon International Plc.
• Develop ultra-bright, full-color MicroLED displays for ground soldier augmented reality (AR) applications under the $15.4 million OTA contract.
• Evaluate the impact of new accounting standards (ASU 2023-09, ASU 2024-03, ASU 2025-06) on financial statements.
• Monitor acceptance of the new product for the 3D automated optical inspection (3DAOI) market.

Key Dates

Recommendation

The company has made significant strides in addressing its liquidity and 'going concern' issues through substantial capital raises and a strategic investment. The reduction in the BlueRadios litigation accrual and the posting of a supersedeas bond also remove a major immediate financial overhang. These developments provide a much-needed foundation for stability. However, the underlying operational performance shows declining revenues and persistent operating losses for the nine-month period, indicating that core business profitability remains a challenge. The continued existence of material weaknesses in internal controls also warrants caution. While the strategic direction with new R&D contracts and partnerships is promising, the execution risk and the time required for these initiatives to translate into sustainable revenue growth and profitability suggest a 'Hold' recommendation. Investors should monitor the remediation of internal control weaknesses, progress on new product development, and the outcome of the BlueRadios appeal.

Keywords

Microdisplays, Augmented Reality (AR), Head-Mounted Displays (HMD), Defense applications, Industrial applications, OLED displays, MicroLED displays, Semiconductor components, SEC 10-Q, Financial results, Litigation, Capital raise, Strategic investment, Kopin Corporation, Wearable technology